Isracann Announces Launch of Early Warrant Exercise Incentive Program and Repricing
January 11, 2021 15:08 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
Isracann Provides Year End Review
December 30, 2019 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...
Isracann Provides Year End Review
December 30, 2019 00:05 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...
Isracann Biosciences Hires Expert Consultancy LinC to Steer Israeli Cannabis Project
November 14, 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a...